{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "21167927", "DateCompleted": {"Year": "2011", "Month": "11", "Day": "07"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2010", "Month": "12", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jep.2010.12.006"], "Journal": {"ISSN": "1872-7573", "JournalIssue": {"Volume": "134", "Issue": "2", "PubDate": {"Year": "2011", "Month": "Mar", "Day": "24"}}, "Title": "Journal of ethnopharmacology", "ISOAbbreviation": "J Ethnopharmacol"}, "ArticleTitle": "Suppression of interleukin (IL)-8 and human beta defensin-2 secretion in LPS-and/or IL-1\u03b2-stimulated airway epithelial A549 cells by a herbal formulation against respiratory infections (BNO 1030).", "Pagination": {"StartPage": "228", "EndPage": "233", "MedlinePgn": "228-33"}, "Abstract": {"AbstractText": ["A special ethanolic-aqueous extract from seven traditional medicinal plants (BNO 1030) has been used for several decades to treat recurrent infections of the respiratory tract. Considering the potential role of interleukin-8 (IL-8) and human beta defensin-2 (hBD-2) in inflammation, we investigated the effect of BNO 1030 on lipopolysaccharide (LPS) from Pseudomonas aeruginosa or IL-1\u03b2-induced inflammatory mediators in A549 human type II alveolar epithelial cells.", "A549 cells were stimulated with LPS (100 \u03bcg/ml) or IL-1\u03b2 (50 ng/ml) in the presence of the preparation and the secretion of IL-8 and hBD-2 were measured after 18 h and 24h in cell free supernatants using enzyme-linked immunosorbent assays (ELISA). Cell viability and cell growth was investigated by propidium iodide uptake and WST-1 assay, respectively.", "BNO 1030 inhibited the secretion of IL-8 and hBD-2 at non-cytotoxic concentrations (0.1-100 \u03bcg/ml; cell growth inhibitory concentration, 50% (IC(50))=678 \u00b1 87.6 \u03bcg/ml). Stimulation by IL-1\u03b2 led to a 7-fold activation of IL-8 secretion, which was reduced by 37.7 \u00b1 4.1% (p<0.05) after incubation with 100 \u03bcg/ml BNO 1030. Inducible hBD-2 was suppressed by 91.8 \u00b1 15.6% (p<0.01) at the same concentration of BNO 1030 (IC(50)=0.7 \u00b1 0.1 \u03bcg/ml). The 2-fold increase of IL-8 secretion by LPS-stimulated cells was completely abolished at concentration of 50 \u03bcg/ml BNO 1030 (IC(50)=5.7\u00b13.6 \u03bcg/ml).", "BNO 1030 suppressed the secretion of IL-8 and hBD-2 in cultured epithelial A549 cells. These results support its use as a phytotherapeutic product prepared from traditional remedies in inflammatory diseases, especially those affecting the respiratory tract."], "CopyrightInformation": "Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, Institute for Complementary Medicine, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland. katarina.hostanska@access.uzh.ch"}], "Identifier": [], "LastName": "Hostanska", "ForeName": "Katarina", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Melzer", "ForeName": "Joerg", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Amon", "ForeName": "Annette", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Saller", "ForeName": "Reinhard", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "J Ethnopharmacol", "NlmUniqueID": "7903310", "ISSNLinking": "0378-8741"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-1beta"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-8"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "beta-Defensins"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": [], "DescriptorName": "Enzyme-Linked Immunosorbent Assay"}, {"QualifierName": ["drug effects"], "DescriptorName": "Epithelial Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Interleukin-1beta"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-8"}, {"QualifierName": [], "DescriptorName": "Lipopolysaccharides"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Pseudomonas aeruginosa"}, {"QualifierName": ["cytology", "drug effects", "metabolism"], "DescriptorName": "Pulmonary Alveoli"}, {"QualifierName": ["metabolism", "microbiology", "prevention & control"], "DescriptorName": "Respiratory Tract Infections"}, {"QualifierName": ["metabolism"], "DescriptorName": "beta-Defensins"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2010", "Month": "6", "Day": "25"}, {"Year": "2010", "Month": "11", "Day": "19"}, {"Year": "2010", "Month": "12", "Day": "6"}, {"Year": "2010", "Month": "12", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "12", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "11", "Day": "8", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["21167927", "10.1016/j.jep.2010.12.006", "S0378-8741(10)00865-2"]}}], "PubmedBookArticle": []}